Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Br J Dermatol ; 175(5): 1049-1051, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26992073

RESUMEN

We present two cases of patients with systemic autoimmune diseases (one with dermatomyositis and one with CREST syndrome) who presented with a worsening of calcinosis cutis after treatment of osteoporosis with teriparatide. To our knowledge, this association is not described in the literature and might be considered in the spectrum of adverse reactions to teriparatide.


Asunto(s)
Conservadores de la Densidad Ósea/efectos adversos , Calcinosis/inducido químicamente , Osteoporosis/tratamiento farmacológico , Enfermedades de la Piel/inducido químicamente , Teriparatido/efectos adversos , Anciano , Síndrome CREST/complicaciones , Dermatomiositis/complicaciones , Femenino , Humanos , Persona de Mediana Edad , Osteoporosis/complicaciones
2.
Int J Neurosci ; 125(12): 936-40, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25350870

RESUMEN

Tumor Necrosis Factor-alpha (TNF-α) is an immunomodulatory and proinflammatory cytokine implicated in neuro-inflammation and neuronal damage in response to cerebral ischemia. The present study tested the hypothesis that anti-TNF-α agents may be protective against cerebral infarction. Transient focal ischemia was artificially induced in anesthetized adult male Wistar rats (300-350 g) by middle cerebral artery occlusion (MCAO) with an intraluminal suture. TNF-α function was interfered with either a chimeric monoclonal antibody against TNF-α (infliximab-7 mg/kg) aiming to TNF-α soluble and membrane-attached form; or a chimeric fusion protein of TNF-α receptor-2 with a fragment crystallizable (Fc) region of IgG1 (etanercept-5 mg/kg) aiming for the TNF-α soluble form. Both agents were administered intraperitoneally 0 or 6 h after inducing ischemia. Infarct volume was measured by 2,3,5-triphenyltetrazolium chloride staining. Cerebral infarct volume was significantly reduced in either etanercept or infliximab-treated group compared with non-treated MCAO rats 24 h after reperfusion. These results suggest that anti-TNF-α agents may reduce focal ischemic injury in rats.


Asunto(s)
Lesiones Encefálicas/prevención & control , Etanercept/uso terapéutico , Infliximab/uso terapéutico , Fármacos Neuroprotectores/uso terapéutico , Factor de Necrosis Tumoral alfa/metabolismo , Animales , Infarto Encefálico/etiología , Infarto Encefálico/prevención & control , Lesiones Encefálicas/etiología , Modelos Animales de Enfermedad , Infarto de la Arteria Cerebral Media/complicaciones , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Masculino , Ratas , Ratas Wistar , Factores de Tiempo , Factor de Necrosis Tumoral alfa/inmunología
3.
Rheumatol Int ; 34(5): 723-5, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-23292188

RESUMEN

We report an adult female patient with Takayasu arteritis (TA) receiving conventional medical treatment and anti-TNF therapy, which developed progressive thoracic and abdominal aortic aneurysms. She developed imminent rupture of the thoracic aneurysm and an endovascular stent-graft (EVSG) was emergency implanted and a year after this procedure the abdominal aneurysm increased in size requiring reoperation and placement of another EVSG. Both procedures had a very good outcome. This case shows the effectivity and security of multiple EVSG implantations in multiple aortic aneurisms in patients with TA.


Asunto(s)
Aneurisma de la Aorta Abdominal/cirugía , Aneurisma de la Aorta Torácica/cirugía , Implantación de Prótesis Vascular/instrumentación , Prótesis Vascular , Procedimientos Endovasculares/instrumentación , Stents , Arteritis de Takayasu/complicaciones , Arteritis de Takayasu/tratamiento farmacológico , Adulto , Aneurisma de la Aorta Abdominal/diagnóstico , Aneurisma de la Aorta Abdominal/etiología , Aneurisma de la Aorta Torácica/diagnóstico , Aneurisma de la Aorta Torácica/etiología , Aortografía/métodos , Productos Biológicos/uso terapéutico , Femenino , Humanos , Reoperación , Arteritis de Takayasu/diagnóstico , Arteritis de Takayasu/inmunología , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores
4.
Rheumatol Int ; 32(2): 541-3, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21267573

RESUMEN

Relapsing polychondritis (RP) is an autoimmune disease characterized by inflammation and destruction of all type of body cartilage, and the cartilage trauma may be a trigger of the disease in a susceptible person. We describe the clinical and laboratory findings in a group of 18 patients with RP with (7 cases) or without (11 cases) anteceding cartilage trauma. The mean age was 41 years in the group with cartilage trauma and 55 years in the group without cartilage trauma. For both groups, female gender was predominant. All patients presented with auricular chondritis. Systemic manifestations and autoimmunity were more common in patients with anteceding trauma.


Asunto(s)
Enfermedades Autoinmunes/diagnóstico , Cartílago/inmunología , Cartílago/lesiones , Policondritis Recurrente/diagnóstico , Heridas y Lesiones/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Enfermedades Autoinmunes/epidemiología , Cartílago/patología , Comorbilidad/tendencias , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Policondritis Recurrente/epidemiología , Policondritis Recurrente/inmunología , Estudios Retrospectivos , Heridas y Lesiones/epidemiología , Heridas y Lesiones/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...